ATE422502T1 - Verfahren zur peptidherstellung - Google Patents

Verfahren zur peptidherstellung

Info

Publication number
ATE422502T1
ATE422502T1 AT00956720T AT00956720T ATE422502T1 AT E422502 T1 ATE422502 T1 AT E422502T1 AT 00956720 T AT00956720 T AT 00956720T AT 00956720 T AT00956720 T AT 00956720T AT E422502 T1 ATE422502 T1 AT E422502T1
Authority
AT
Austria
Prior art keywords
peptide
cationic
amino acids
sectors
producing peptides
Prior art date
Application number
AT00956720T
Other languages
English (en)
Inventor
Oeystein Rekdal
John Sigurd Svendsen
Mari Wikman
Terese Solstad
Nannan Yang
Original Assignee
Lytix Biopharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB1999/002851 external-priority patent/WO2000012542A2/en
Application filed by Lytix Biopharma As filed Critical Lytix Biopharma As
Application granted granted Critical
Publication of ATE422502T1 publication Critical patent/ATE422502T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Semiconductor Lasers (AREA)
AT00956720T 1999-08-31 2000-08-31 Verfahren zur peptidherstellung ATE422502T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/GB1999/002851 WO2000012542A2 (en) 1998-08-28 1999-08-31 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
GBGB0005702.6A GB0005702D0 (en) 2000-03-09 2000-03-09 Method

Publications (1)

Publication Number Publication Date
ATE422502T1 true ATE422502T1 (de) 2009-02-15

Family

ID=9887296

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00956720T ATE422502T1 (de) 1999-08-31 2000-08-31 Verfahren zur peptidherstellung

Country Status (14)

Country Link
US (1) US7393824B1 (de)
EP (1) EP1259536B1 (de)
JP (1) JP4902919B2 (de)
AT (1) ATE422502T1 (de)
AU (1) AU781243B2 (de)
CA (1) CA2382544A1 (de)
CY (1) CY1109450T1 (de)
DE (1) DE60041556D1 (de)
DK (1) DK1259536T3 (de)
ES (1) ES2322228T3 (de)
GB (1) GB0005702D0 (de)
NO (1) NO330170B1 (de)
PT (1) PT1259536E (de)
WO (1) WO2001019852A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US8283315B2 (en) 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
GB0005703D0 (en) * 2000-03-09 2000-05-03 Alpharma As Compounds
NO20031818D0 (no) * 2003-04-23 2003-04-23 Uni I Tromsoe Fremgangsmåte av bioaktiv peptid forberedelse
AU2006266609C1 (en) * 2005-07-05 2011-10-27 Biotempt B.V. Treatment of tumors
EP1864692A1 (de) 2006-06-07 2007-12-12 Biotempt B.V. Verwendung von peptiden zum Schutz von Strahlenschäden
AU2009206212B2 (en) 2008-01-24 2014-01-16 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Lytic domain fusion constructs and methods of making and using same
GB0821616D0 (en) 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
WO2013124436A1 (en) * 2012-02-23 2013-08-29 University Of East London Synthetic anti-microbial peptides with a minority of cationic and a majority hydrophobic side chains
IL238323B2 (en) 2012-10-30 2023-11-01 Esperance Pharmaceuticals Inc Antibody/drug conjugates and methods of use
GB201401877D0 (en) * 2014-02-04 2014-03-19 Univ Tromsoe Peptides
US20170296629A1 (en) * 2014-10-08 2017-10-19 Keio University Inhibitor of extracellular trap formation in leukocyte
GB201810635D0 (en) * 2018-06-28 2018-08-15 Norut Northern Res Institute As Peptides and cancer treatment
CN111704652B (zh) * 2020-06-02 2022-04-22 昆明医科大学 一种抗光损伤皮肤保护活性多肽om-gl15及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547939A (en) * 1991-06-14 1996-08-20 The Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
AU5386996A (en) * 1995-04-05 1996-10-23 Picower Institute For Medical Research, The Agents for binding to advanced glycosylation endproducts, an d methods of their use
WO1998006425A1 (en) * 1996-08-12 1998-02-19 A+ Science Invest Ab Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
JP2002515893A (ja) * 1997-02-03 2002-05-28 ファーミング インテレクチュアル プロパティ ビーブイ ヒトラクトフェリンおよびその改変体の有用な特性
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides

Also Published As

Publication number Publication date
NO20020950L (no) 2002-04-25
WO2001019852A8 (en) 2004-04-15
JP4902919B2 (ja) 2012-03-21
CA2382544A1 (en) 2001-03-22
AU781243B2 (en) 2005-05-12
PT1259536E (pt) 2009-05-14
DK1259536T3 (da) 2009-06-08
EP1259536B1 (de) 2009-02-11
CY1109450T1 (el) 2014-08-13
GB0005702D0 (en) 2000-05-03
AU6858700A (en) 2001-04-17
WO2001019852A2 (en) 2001-03-22
JP2003516931A (ja) 2003-05-20
EP1259536A2 (de) 2002-11-27
NO20020950D0 (no) 2002-02-27
NO330170B1 (no) 2011-02-28
US7393824B1 (en) 2008-07-01
WO2001019852A3 (en) 2002-09-12
DE60041556D1 (de) 2009-03-26
ES2322228T3 (es) 2009-06-18

Similar Documents

Publication Publication Date Title
CY1109450T1 (el) Μεθοδοι παρασκευης πεπτιδιων
DE69512794D1 (de) Kombinatorische pna-bibliotheken und verbesserte syntheseverfahren
CA2184908A1 (en) Human osteoclast-derived cathepsin
ATE380195T1 (de) Zusammensetzungen und verfahren zur behandlung von tumoren
AU6160201A (en) Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells
BR0011500A (pt) Hialuronidase de hirudinaria manillensis, isolamento, purificação e método recombinante de produção
EP1118660A4 (de) Ein plasmaprotein-fragment erzeugendes enzym mit krebsmetastase-hemmender wirkung und durch dieses enzym fragmentiertes plasmaprotein-fragment
HUP0100267A2 (hu) Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények
ATE356145T1 (de) Polypeptide zur regenerierung des nervensystems
DE69524415D1 (de) UNGESPLEISSTE VARIANTEN DES gp350/220
WO2004094462A3 (en) Methods of peptide preparation
MXPA02012308A (es) Nuevo interferon para el tratamiento de esclerosis multiple.
ATE309265T1 (de) Peptidverbindung, die von einem verschobenen offenen leserahmen des ice-gens abstammt
FR2813606B1 (fr) Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
WO2002000824A3 (fr) Nouveau polypeptide, proteine humaine 10.56 du gene cancerigene tre, et polynucleotide codant ce polypeptide
WO2001075048A3 (fr) Nouveau polypeptide, proteine ribosomale humaine s11 23, et polynucleotide codant pour ce polypeptide
WO2001075012A3 (fr) Nouveau polypeptide, peptide signal humain 10 d'une proteine precurseur de la lipoproteine, et polynucleotide codant pour ce polypeptide
WO2001075057A3 (fr) Nouveau polypeptide, proteine ribosomale s4 humaine 12, et polynucleotide codant pour ce polypeptide
WO2001075002A3 (fr) Nouveau polypeptide, gène de regulation du cycle cellulaire humain 28, et polynucléotide codant pour ce polypeptide
WO2001083682A3 (fr) Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide
WO2001075007A3 (fr) Nouveau polypeptide, tyrosinase 15, et polynucléotide codant pour ce polypeptide
WO2001075046A3 (fr) Nouveau polypeptide, gene humain de regulation 17 du cycle mitotique, et polynucleotide codant pour ce polypeptide
MX9806628A (es) Gen de respuesta de diferenciacion terminal mieloide humana novedoso.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1259536

Country of ref document: EP